Medicare National Coverage Determination- Infusion Pumps: C-Peptide Levels as A Criterion for Use
Guidance for plans informing that effective for services performed on or after December 17, 2004, a positive fasting beta cell autoantibody test is added as an adequate diagnostic criterion as an alternative to insulinopenia per the updated C-peptide testing requirement. .
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: February 04, 2005
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.